AMP-Activated Protein Kinase: Maintaining Energy Homeostasis at the Cellular and Whole-Body Levels, Annual Review of Nutrition, vol.34, issue.1, pp.31-5510, 2014. ,
DOI : 10.1146/annurev-nutr-071812-161148
Regulation of HMG-CoA reductase: identification of the site phosphorylated by the AMP-activated protein kinase in vitro and in intact rat liver, Embo J, vol.9, issue.8, pp.2439-2446, 1990. ,
Purification and characterization of the AMP-activated protein kinase. Copurification of acetyl-CoA carboxylase kinase and 3-hydroxy-3-methylglutaryl-CoA reductase kinase activities, European Journal of Biochemistry, vol.255, issue.1-2, pp.129-136, 1989. ,
DOI : 10.1042/bj2020117
Regulation of hepatic metabolism by AMPK, Journal of Hepatology, vol.54, issue.4, pp.827-829, 2011. ,
DOI : 10.1016/j.jhep.2010.09.014
URL : https://hal.archives-ouvertes.fr/inserm-00555334
Treatment of nonalcoholic fatty liver disease: role of AMPK, American Journal of Physiology-Endocrinology and Metabolism, vol.309, issue.4, p.311, 2016. ,
DOI : 10.1172/JCI13505
A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis, EMBO Mol Med, vol.6, issue.4, pp.519-538, 2014. ,
Salicylate activates AMPK and synergizes with metformin to reduce the survival of prostate and lung cancer cells ex vivo through inhibition of de novo lipogenesis, Biochem J, vol.469, issue.2, pp.177-18710, 1042. ,
Activation of AMPK restricts coxsackievirus B3 replication by inhibiting lipid accumulation, Journal of Molecular and Cellular Cardiology, vol.85, pp.155-167, 2015. ,
DOI : 10.1016/j.yjmcc.2015.05.021
Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome, Cell Metabolism, vol.3, issue.6, pp.403-416, 2006. ,
DOI : 10.1016/j.cmet.2006.05.005
Mechanism of Action of Compound-13: An ??1-Selective Small Molecule Activator of AMPK, Chemistry & Biology, vol.21, issue.7, pp.866-879, 2014. ,
DOI : 10.1016/j.chembiol.2014.05.014
Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin, Nat Med, vol.19, issue.12, pp.1649-1654, 2013. ,
A Potent and Selective AMPK Activator That Inhibits de Novo Lipogenesis, ACS Med Chem Lett, vol.1, issue.9, pp.478-482, 2010. ,
Enhanced activation of cellular AMPK by dual-small molecule treatment: AICAR and A769662, Am J Physiol Endocrinol Metab, vol.306, issue.6, pp.688-696, 2014. ,
Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state, J Clin Invest, vol.120, issue.7, pp.2355-2369, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-00495746
Conditions affecting primary cell cultures of functional adult rat hepatocytes, In Vitro, vol.256, issue.12, pp.821-832, 1976. ,
DOI : 10.1093/geronj/22.2.174
Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain, Biochem J, p.348, 2000. ,
Dimethylbiguanide Inhibits Cell Respiration via an Indirect Effect Targeted on the Respiratory Chain Complex I, Journal of Biological Chemistry, vol.1364, issue.2, pp.223-228, 2000. ,
DOI : 10.1002/(SICI)1099-1263(199711/12)17:6<409::AID-JAT462>3.0.CO;2-B
URL : https://hal.archives-ouvertes.fr/inserm-00390049
Structural basis of AMPK regulation by small molecule activators, Nature Communications, vol.269, pp.301710-4017, 1038. ,
DOI : 10.1107/S0907444994003112